StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > How quick these pumpers forget…

<< Previous

Bullboard Posts

Next >>

Comment by TrippinAgain01on Jan 21, 2023 9:00pm

214 Views

Post# 35237867

RE:RE:RE:How quick these pumpers forget…

2020, 2021, 2022....? With exception to the 95% share price drop, the fake launch, and the analyst running for his life, NOTHING HAPPENED! You say I got the 2019 numbers wrong and you were finally correct!

I always quote 160K but it was only actually 138K total revenue. PATHETIC!

Any person who tell their entire shareholder base they are expecting 30 million in revenue confidently like a dozen times and then can only produce 138K is a bonified moron or criminal. Take your pick.

YOU MUST HAVE NO BRAIN AND BE CLINICALLY INSANE TO GIVE MORE OF YOUR MONEY TO THIS SAME PERSON.

User image